FBRX
FBRX
NASDAQ · Biotechnology

Forte Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$25.15
-1.02 (-3.90%)
As of May 9, 1:53 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -68.3% upside
Low Target $5.39
Average Target $7.97
High Target $9.61
Current Price $25.15
Current
$25.15
Target
$7.97
$5.39 $7.97 avg $9.61
Scenario Analysis
Bear Case
$5.39
-78.6%
Low target
Base Case
$7.97
-68.3%
Avg target
Bull Case
$9.61
+-61.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$35.80
-29.7% from high
52-Week Low
$6.13
+310.3% from low
Target vs 52W High
$7.97
-77.7% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-1.22
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%